Emerald Scofield

→

People

Emerald Scofield

Investment Manager
Emerald Scofield

Emerald is an Investment Manager at Main Sequence, backing deep tech founders with a focus on climate tech, biotech and healthcare. She joined the firm in 2023 as an Associate and was promoted to Investment Manager in 2025.

Before joining Main Sequence, Emerald built her venture and operating experience across New Zealand’s deep tech ecosystem. She spent five years in deep tech venture capital while concurrently holding operating and governance roles across several early-stage companies. She served as Operations Manager and later Board Observer at medtech company Orbis Diagnostics, and held roles including Interim Operations Manager, Acting CEO and Board Observer at climate tech startup Dewpoint Innovations. Emerald also served as a Board Observer at TasmanIon and as a Trustee of the Talalelei Life Futures Fund.

Emerald holds a Bachelor of Science in Biotechnology from the University of Auckland. Emerald is Main Sequence’s nominee director on portfolio company Facet Amtech.

Portfolio

For founders

Building for the systems that matter? Pitch us.

We back founders turning breakthrough science into category-defining companies.

Submit your pitch
For investors

Invest with Main Sequence

Access Australia's deep tech frontier alongside us.

Investor enquiries